Growth Metrics

Electromed (ELMD) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Electromed 300.53 Mn 283.55 Mn 14.64 Mn 75.23%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 75.23%
Dec 31, 2025 30.42%
Sep 30, 2025 28.05%
Jun 30, 2025 93.29%
Mar 31, 2025 135.40%
Dec 31, 2024 88.56%
Sep 30, 2024 81.80%
Jun 30, 2024 81.32%
Mar 31, 2024 17.49%
Dec 31, 2023 73.12%
Sep 30, 2023 -31.94%
Jun 30, 2023 -8.02%
Mar 31, 2023 -10.09%
Dec 31, 2022 -0.74%
Sep 30, 2022 -67.42%
Jun 30, 2022 -36.10%
Mar 31, 2022 -23.23%
Dec 31, 2021 -3.17%
Sep 30, 2021 -57.43%
Jun 30, 2021 9.70%
Mar 31, 2021 34.55%
Dec 31, 2020 -17.73%
Sep 30, 2020 35.81%
Jun 30, 2020 49.37%
Mar 31, 2020 5.02%
Dec 31, 2019 3.59%
Sep 30, 2019 36.03%
Jun 30, 2019 41.87%
Mar 31, 2019 -11.29%
Dec 31, 2018 -15.42%
Sep 30, 2018 -0.93%
Jun 30, 2018 -15.64%
Mar 31, 2018 -12.31%
Dec 31, 2017 48.17%
Sep 30, 2017 -29.95%
Jun 30, 2017 -28.35%
Mar 31, 2017 107.01%
Dec 31, 2016 47.62%
Sep 30, 2016 -53.81%
Jun 30, 2016 -17.57%
Mar 31, 2016 63.55%
Dec 31, 2015 -7.71%
Sep 30, 2015 39.79%
Jun 30, 2015 23.24%
Mar 31, 2015 76.11%
Dec 31, 2014 36.09%
Sep 30, 2014 46.75%
Jun 30, 2014 111.80%
Mar 31, 2014 52.47%
Dec 31, 2013 61.74%
Sep 30, 2013 141.83%